Ciprofibrate |
52214-84-3 |
2-(4-(2,2-dichlorocyclopropyl)phenoxy)-2-methylpropanoic acid |
Lipanor |
Ciprofibratum |
2-4-(2,2-Dichlorocyclopropyl)phenoxy-2-methylpropanoic acid |
Ciprofibrato |
Modalim |
WIN 35833 |
Win-35833 |
Propanoic acid, 2-4-(2,2-dichlorocyclopropyl)phenoxy-2-methyl- |
2-(4-(2,2-Dichlorocyclopropyl)phenoxy)2-methylpropanoic acid |
MFCD00467135 |
2-(p-(2,2-Dichlorocyclopropyl)phenoxy)-2-methylpropionic acid |
CHEBI:50867 |
NCGC00164447-01 |
2-p-(2,2-Dichlorocyclopropyl)phenoxy-2-methylpropanoic acid |
2-{4-(2,2-dichlorocyclopropyl)phenyloxy}-2-methylpropanoic acid |
DSSTox_CID_331 |
Propanoic acid, 2-(4-(2,2-dichlorocyclopropyl)phenoxy)-2-methyl- |
DSSTox_RID_75519 |
DSSTox_GSID_20331 |
Ciprofibratum INN-Latin |
Ciprofibrato INN-Spanish |
C13H14Cl2O3 |
Hiperlipen |
Ciprol |
SMR000857190 |
CCRIS 173 |
SR-01000075734 |
EINECS 257-744-6 |
Ciprofibrate (USAN/INN) |
BRN 1984981 |
2-p-(2,2-dichlorocyclopropyl)phenoxy-2-methylpropionic acid |
Ciprofibrate? |
Ciprofibrate USAN:INN:BAN |
CAS-52214-84-3 |
Ciprofibrate- Bio-X |
Prestwick0_001076 |
Prestwick1_001076 |
Prestwick2_001076 |
Prestwick3_001076 |
C 0330 |
Lopac0_000168 |
SCHEMBL26870 |
BSPBio_001092 |
MLS002154143 |
MLS006011758 |
Win35833 |
SPBio_002996 |
BPBio1_001202 |
CHEMBL557555 |
GTPL3438 |
DTXSID8020331 |
AOB6803 |
BCPP000277 |
HMS1571G14 |
HMS2098G14 |
HMS2235J14 |
HMS3260B17 |
HMS3369B22 |
HMS3656P09 |
HMS3715G14 |
Pharmakon1600-01502008 |
BCP03728 |
EBD38709 |
HY-B0664 |
Tox21_112121 |
Tox21_201359 |
Tox21_302840 |
Tox21_500168 |
BBL010821 |
BDBM50371235 |
NSC759617 |
Propionic acid, 2-(4-(2,2-dichlorocyclopropyl)phenoxy)-2-methyl- |
s2665 |
STK624758 |
AKOS005557843 |
Tox21_112121_1 |
AC-1018 |
BCP9000533 |
CCG-204263 |
DB09064 |
KS-1201 |
LP00168 |
MCULE-8060052925 |
NSC 759617 |
NSC-759617 |
SDCCGSBI-0050156.P002 |
NCGC00015202-02 |
NCGC00015202-03 |
NCGC00015202-04 |
NCGC00015202-05 |
NCGC00015202-06 |
NCGC00015202-08 |
NCGC00015202-20 |
NCGC00015202-21 |
NCGC00093652-01 |
NCGC00093652-02 |
NCGC00256361-01 |
NCGC00258911-01 |
NCGC00260853-01 |
BD164311 |
BCP0726000148 |
AB0010540 |
AB00514032 |
EU-0100168 |
FT-0602946 |
SW197242-4 |
D03521 |
O10468 |
AB00514032_06 |
214C843 |
A828985 |
J-520054 |
Q3496452 |
SR-01000075734-1 |
SR-01000075734-4 |
SR-01000075734-7 |
BRD-A49358627-001-03-9 |
BRD-A49358627-001-10-4 |
2-4-(2,2-Dichlorocyclopropyl)phenoxy-2-methylpropionic Acid |
4-(1,2,3,6-TETRAHYDROPYRIDIN-4-YL)PHENOLHYDROCHLORIDE |
Ciprofibrate, European Pharmacopoeia (EP) Reference Standard |
2-4-2,2-bis(chloranyl)cyclopropylphenoxy-2-methyl-propanoic acid |
Ciprofibrate for system suitability, European Pharmacopoeia (EP) Reference Standard |